chr4-3160329-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001388492.1(HTT):​c.3801C>T​(p.Leu1267Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.294 in 1,552,978 control chromosomes in the GnomAD database, including 71,274 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 5646 hom., cov: 32)
Exomes 𝑓: 0.30 ( 65628 hom. )

Consequence

HTT
NM_001388492.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.59

Publications

23 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 4-3160329-C-T is Benign according to our data. Variant chr4-3160329-C-T is described in ClinVar as Benign. ClinVar VariationId is 1599466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.6 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.367 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HTTNM_001388492.1 linkc.3801C>T p.Leu1267Leu synonymous_variant Exon 29 of 67 ENST00000355072.11 NP_001375421.1
HTTNM_002111.8 linkc.3801C>T p.Leu1267Leu synonymous_variant Exon 29 of 67 NP_002102.4 P42858

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HTTENST00000355072.11 linkc.3801C>T p.Leu1267Leu synonymous_variant Exon 29 of 67 1 NM_001388492.1 ENSP00000347184.5 P42858

Frequencies

GnomAD3 genomes
AF:
0.240
AC:
36523
AN:
152040
Hom.:
5641
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0594
Gnomad AMI
AF:
0.246
Gnomad AMR
AF:
0.251
Gnomad ASJ
AF:
0.313
Gnomad EAS
AF:
0.381
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.441
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.307
Gnomad OTH
AF:
0.215
GnomAD2 exomes
AF:
0.287
AC:
45697
AN:
159328
AF XY:
0.281
show subpopulations
Gnomad AFR exome
AF:
0.0506
Gnomad AMR exome
AF:
0.286
Gnomad ASJ exome
AF:
0.310
Gnomad EAS exome
AF:
0.379
Gnomad FIN exome
AF:
0.438
Gnomad NFE exome
AF:
0.299
Gnomad OTH exome
AF:
0.274
GnomAD4 exome
AF:
0.300
AC:
420467
AN:
1400820
Hom.:
65628
Cov.:
32
AF XY:
0.297
AC XY:
205228
AN XY:
691090
show subpopulations
African (AFR)
AF:
0.0468
AC:
1498
AN:
31992
American (AMR)
AF:
0.277
AC:
9939
AN:
35856
Ashkenazi Jewish (ASJ)
AF:
0.308
AC:
7738
AN:
25164
East Asian (EAS)
AF:
0.373
AC:
13598
AN:
36452
South Asian (SAS)
AF:
0.187
AC:
14851
AN:
79384
European-Finnish (FIN)
AF:
0.428
AC:
21194
AN:
49482
Middle Eastern (MID)
AF:
0.124
AC:
708
AN:
5700
European-Non Finnish (NFE)
AF:
0.310
AC:
334597
AN:
1078738
Other (OTH)
AF:
0.282
AC:
16344
AN:
58052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
14446
28893
43339
57786
72232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11102
22204
33306
44408
55510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.240
AC:
36530
AN:
152158
Hom.:
5646
Cov.:
32
AF XY:
0.243
AC XY:
18051
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.0592
AC:
2460
AN:
41554
American (AMR)
AF:
0.252
AC:
3846
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.313
AC:
1086
AN:
3470
East Asian (EAS)
AF:
0.381
AC:
1965
AN:
5162
South Asian (SAS)
AF:
0.190
AC:
917
AN:
4830
European-Finnish (FIN)
AF:
0.441
AC:
4661
AN:
10574
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.307
AC:
20861
AN:
67966
Other (OTH)
AF:
0.222
AC:
467
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1310
2621
3931
5242
6552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
386
772
1158
1544
1930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.269
Hom.:
6815
Bravo
AF:
0.220
Asia WGS
AF:
0.304
AC:
1057
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
5.2
DANN
Benign
0.47
PhyloP100
1.6
PromoterAI
0.014
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs363099; hg19: chr4-3162056; COSMIC: COSV61870509; COSMIC: COSV61870509; API